Excipient Portfolio for Parenteral Formulations

About DFE Pharma

DFE Pharma operates as a specialized supplier of essential excipients, which are inert substances that serve as the delivery vehicle or stabilizer for active pharmaceutical ingredients (APIs). The company positions itself as a critical partner to drug manufacturers, providing solutions that ensure product stability, predictable release, and manufacturability, with its excipients used in major treatments including COVID-19 vaccines. Its business model is based on manufacturing and services within the drug delivery sector, serving a broad global market. As a private company, it leverages deep technical expertise and a commitment to quality and supply chain reliability to maintain its market leadership.